STOCKS NEWS UK-ReNeuron soars on talk of trial update

STOCKS NEWS Reuters Results diary

Europe [STXNEWS/EU] Real-time Equity News [E] [GB/EQUITY]

UK [STXNEWS/UK] Stocks on the move [HOT-RTRS]

UK smallcaps [STX/UKSC] UK smallcaps news [GB/SMALL]

15:05 GMT 23Jun2009-ReNeuron soars on talk of trial update

----------------------------------------------------------

Shares in stem cell specialist ReNeuron (RQE.L) rise as much as 25 percent, with traders pointing to talk it is close to announcing it has received the green light to start human trials of its therapy for stroke victims.

"There's been a massive retail demand for these (shares) over the last few hours. They're talking them up on the internet boards," said a trader.

ReNeuron is waiting for approval from the British Gene Therapy Advisory Committee before it can go ahead with the Phase 1 tests. The company is due to attend a European Partnering Conference for biotechnology companies in London on Thursday and will announce its full-year results on June 30.

"There might be speculation that along with the results announcement there is something else to be announced," said Jacob Plieth, analyst at Edison Investment Research. Nobody at the company was immediately available for comment. Posters on investment Web sites said they expected the company to make an announcement in the coming days.

Reuters messaging rm://ben.deighton.reuters.com@reuters.net

rm://matthew.scuffham.reuters.com@reuters.net

13:03GMT 23Jun2009-Bunzl gains after update

----------------------------------

Shares in Bunzl (BNZL.L) gain 2.3 percent after the British distribution group says its overall trading in the year-to-date has been in line with full-year expectations but the challenging economic environment put pressure on margins.